Answer to the letter of Lippi & Plebani entitled "Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal"

Clin Chim Acta. 2022 Feb 1:526:21-22. doi: 10.1016/j.cca.2021.12.021. Epub 2021 Dec 25.

Authors

Giacomo Malipiero¹, Danilo Villalta²

Affiliations

¹ Immunologia e Allergologia, Ospedale Santa Maria degli Angeli, Pordenone, Italy.
² Immunologia e Allergologia, Ospedale Santa Maria degli Angeli, Pordenone, Italy. Electronic address: danilo.villalta@asfo.sanita.fvg.it.

No abstract available

Keywords: BNT162b2; Neutralizing antibody; SARS-CoV-2; anti-S-RBD.

Publication types

Letter
Comment

MeSH terms

Antibodies, Neutralizing
Antibodies, Viral
COVID-19*
Humans
Immunoglobulin G
SARS-CoV-2*

Substances

Antibodies, Neutralizing
Antibodies, Viral
Immunoglobulin G